oasis 1 oral semaglutide 50 mg obesity nejm 2023 trial Higher-dose oral semaglutide may be beneficial option for type 2 diabetes, obesity Oral Semaglutide 25 mg Demonstrates

Further, it provided improved risk stratification of CAC progression beyond known prognosticators

This dose-response relationship is referred to as a monophasic dose-relationship

Add in potential GI side effects like diarrhea, and dehydration can hit hard

References: Cani PD et al., 2019 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation

Like Ozempic, many doctors have prescribed Victoza off-label for weight loss

What happens when you stop GLP-1: before and after discontinuation No discussion of GLP-1 before and after is complete without addressing what happens when the medication stops